Trademark Overview
On Friday, February 3, 2023, a trademark application was filed for GUARDANT GALAXY with the United States Patent and Trademark Office. The USPTO has given the GUARDANT GALAXY trademark a serial number of 97779986. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Guardant Health, Inc.. The GUARDANT GALAXY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Healthcare services, namely, providing a database in the field of cancer related information and featuring inputting and collection of data and information for diagnostic purposes; medical testing of blood for diagnostic or cancer screening purposes; providing cancer screening services in the nature of providing medical diagnostic testing services consisting primarily of chemical analysis and use of bioinformatics tools for cancer detection; providing a website featuring information in the field of cancerous diseases for diagnostic and cancer screening purposes; providing a website featuring information in the field of cancerous diseases for medical purposes; Medical diagnostic testing, monitoring and reporting service; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment
Scientific research for medical purposes in the area of cancerous diseases; structural and functional analysis of genomes; providing a website featuring information in the field of cancerous diseases for scientific purposes; Platform as a service (PAAS) featuring computer software platforms for conducting, reviewing, and analyzing cancer tests; Providing a website featuring non-downloadable software using artificial intelligence for conducting, reviewing, and analyzing cancer tests; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for conducting, reviewing, and analyzing cancer images and tests; Providing medical testing services and information in the field of cancer research and disease classification; Medical research services in the field of cancer; Pharmaceutical drug development services
